SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

IND-SWIFT LABORATORIES

BSE: 532305 29 Jul 2025
Healthcare
₹ 107.05
Ind-Swift Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

IND-SWIFT LABORATORIES - Share Price & Details

Market Cap
₹641.0
High /Low
186.0 / 67.2
Stock P/E
7.76
Book Value
₹171.0
Dividend Yield
0.0
ROCE
19.6
ROE
₹17.4
Face Value
10.0
PEG Ratio
0.03
EVEBITDA
₹2.11
Debt
16.4
CMP / FCF
16.8
Debt to equity
₹0.02
NP Ann
421
High price all time
242.0
Piotroski score
₹6.0
Graham Number
480.0
No. Eq. Shares
6.06
Net CF
₹431
Net profit
354
Price to book value
0.62
Interest Coverage
₹8.37
Low price all time
15.0
Industry PE
33.4
Reserves
₹952
Free Cash Flow
₹-205

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,3.25-4.52NA-18.440
IND-SWIFT LABORATORIES LTD.NANANANA641.07.76
KERALA AYURVEDA LTD.320.46-155.36313.19-13.68582
JENBURKT PHARMACEUTICALS LTD.429.2785.37410.4719.3457718.4

Peer Comparison Chart


About IND-SWIFT LABORATORIES

Ind-Swift Laboratories Ltd., with Security Code 532305, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Ind-Swift Labs soars 59% following InvestingPro’s May fair value alert By Investing.com

(10 Jul 2025)
Investing.com's Fair Value models have once again demonstrated their effectiveness in identifying market opportunities, with Indian...
Read more →

Eimco Elecon (India) Ltd leads losers in 'B' group

(10 Jul 2025)
Ind-Swift Laboratories Ltd, Fischer Medical Ventures Ltd, Robust Hotels Ltd and Bang Overseas Ltd are among the other losers in the BSE's...
Read more →

Ind-Swift Laboratories Ensures Compliance with SEBI Regulations

(03 Jul 2025)
Ind-Swift Laboratories Ltd. has submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
Read more →

There's No Escaping Ind-Swift Laboratories Limited's (NSE:INDSWFTLAB) Muted Revenues Despite A 46% Share Price Rise

(24 Jun 2025)
There's No Escaping Ind-Swift Laboratories Limited's (NSE:INDSWFTLAB) Muted Revenues Despite A 46% Share Price Rise ... Ind-Swift Laboratories...
Read more →

Who are in the management team of Ind-Swift Labs.?

(08 Jun 2025)
As of March 2019, the management team of Ind-Swift Labs includes N R Munjal (Chairman & Managing Director), Himanshu Jain (Joint Managing...
Read more →

Ind-Swift Laboratories Faces Mixed Technical Trends Amid Market Volatility

(29 May 2025)
Ind-Swift Laboratories, a microcap in the Pharmaceuticals and Biotechnology sector, has experienced notable stock fluctuations, with a recent trading range...
Read more →

Company Updates